Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 13, 2025 16:02 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Reports Third Quarter 2025 Financial Results

BioStem Technologies Reports Third Quarter 2025 Financial Results
November 13, 2025 16:01 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Announces Filing of Restated Financial Statements

BioStem Technologies Announces Filing of Restated Financial Statements
November 10, 2025 08:00 ET | Source: Vaxxas Pty Ltd

Vaxxas Appoints Veteran Vaccine Leader to Board as Company Advances Needle-Free Vaccine Patch Towards Market

Australian needle-free vaccine patch company Vaxxas appoints global pharmaceutical executive to Board as it accelerates product to market.
November 06, 2025 08:30 ET | Source: SS Innovations

SS Innovations Announces Successful Completion of First Telesurgery Performed with the Company’s SSi Mantra Tele Surgeon Console

SS Innovations Announces Successful Completion of First Telesurgery Performed with the Company’s SSi Mantra Tele Surgeon Console
November 06, 2025 08:00 ET | Source: Route 92 Medical, Inc.

Route 92 Medical Appoints Medtech Industry Leader Pat Mackin to its Board of Directors

Route 92 Medical Appoints Medtech Industry Leader Pat Mackin to its Board of Directors
November 06, 2025 08:00 ET | Source: Hatteras Venture Partners

Hatteras Venture Partners Honors HistoSonics with the Charles A. Sanders Award for Entrepreneurial Excellence

Hatteras Venture Partners honors HistoSonics with the Charles A. Sanders Award for Entrepreneurial Excellence
November 06, 2025 07:30 ET | Source: EDAP TMS S.A.

EDAP Reports Third Quarter 2025 Financial Results

EDAP Reports Third Quarter 2025 Financial Results 49% YoY HIFU Revenue Growth, Driven by Increased Focal One® Sales and U.S. Procedure Volumes167% YoY Growth in Focal One System Placements15% YoY...
November 05, 2025 16:05 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes

BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes
November 05, 2025 08:30 ET | Source: Microbot Medical Inc.

Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.

Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
November 05, 2025 07:00 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters

BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters